Syncom Healthcare Peer Comparison

NSE: SYNCOM | BSE: 533157

₹4.20

₹0.05 (1.20%)

As on 28-Jun-2021IST

Market cap

₹16 Cr

Revenue (TTM)

₹5 Cr

P/E Ratio

--

P/B Ratio

-1

Div. Yield

0 %

Edit

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Market cap (₹ Cr)	16	34,375	27,466	26,764	26,847
Revenue (₹ Cr)	5	3,564	9,205	1,936	1,462
Net Profit (₹ Cr)	-6.07	414.00	-371.81	288.22	387.35
Net Margin (%)	-107.88	11.23	-3.93	14.79	26.01
RoE (%)	--	8.38	-3.85	29.77	25.18
Price to Earnings	--	84.05	--	92.86	69.51
Price-To-Book	-0.95	6.83	3.43	19.94	15.56

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Operating Revenue	4.87	2,798.00	8,171.16	853.89	717.47
Total Income	5.63	2,881.00	8,372.30	872.39	724.97
Total Expenditure	8.05	2,759.00	7,000.65	699.30	588.98
EBITDA	-3.18	39.00	1,170.51	154.59	128.49
Depreciation	1.93	223.00	740.57	38.97	16.06
EBIT	-5.10	-184.00	429.94	115.62	112.43
Interest	1.73	305.00	448.49	31.26	5.94
Other Income	0.76	83.00	201.14	18.50	7.49
Exceptional Items	--	-14.00	-62.79	--	-32.08
Profit before Tax	-6.07	-420.00	179.29	102.86	81.90
Provision for Tax	--	52.00	161.47	11.85	33.19
Profit after Tax	-6.07	-472.00	17.82	91.01	48.71

Liabilities (₹ Cr)

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Shareholder's Funds	-9.30	3,359.00	7,911.37	385.00	674.00
Minority Interest	--	303.00	--	--	8.76
Non-Current Liabilities	5.31	617.00	2,644.64	151.06	127.98
Current Liabilities	23.43	2,791.00	4,369.30	572.50	285.17
Total Liabilities	19.44	7,614.00	15,082.63	1,109.49	1,095.90

Assets (₹ Cr)

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Non-Current Assets	12.97	4,886.00	9,460.84	345.40	602.60
Current Assets	6.47	2,073.00	5,464.47	763.17	493.30
Total Assets	19.44	7,614.00	15,082.63	1,109.49	1,095.90
Total Debt*	22.60	2,112.00	4,558.86	396.41	216.65
Net Current Assets	-16.96	-718.00	1,095.17	190.67	208.13
Contingent Liabilities	--	882.46	61.43	10.24	2.07

Cashflow (₹ Cr)

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Cash From Operating Activities	-1.10	219.00	1,004.54	21.01	125.17
Cash Flow from Investing Activities	-0.96	-137.00	-434.01	-68.51	-365.39
Cash from Financing Activities	1.67	334.00	-422.36	43.55	239.36
Net Cash Inflow / Outflow	-0.39	416.00	148.17	-3.95	-0.86

Ratios

Profitability Ratios

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
ROCE (%)	-29.65	-2.15	5.07	19.36	11.81
ROE (%)	0.00	-14.12	0.24	28.75	7.70
ROA (%)	-30.00	-6.67	0.12	9.80	5.23
EBIT Margin (%)	-49.59	4.36	16.79	20.27	18.95
Net Margin (%)	-107.88	-16.38	0.21	10.43	6.72
Cash Profit Margin (%)	-85.20	-6.91	8.05	15.22	9.03

Growth Ratios

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Revenue Growth (%)	61.46	5.55	15.39	116.99	16.33
EBIT Growth (%)	-22.83	-45.29	60.74	293.63	7.13
Net Profit Growth (%)	-12.75	23.99	109.56	638.92	-41.52
EPS Growth (%)	-12.75	22.55	108.83	638.92	-49.26
Book Value Growth (%)	-188.43	0.24	16.39	32.89	13.09

Valuation Ratios

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Price / Earnings	0.00	0.00	956.95	0.00	47.18
Price / Book Value	0.00	2.69	2.16	0.00	6.01
Dividend Yield (%)	--	0.00	0.09	--	0.27
EV/EBITDA	-10.60	86.64	15.40	2.04	30.88
Market Cap (₹ Cr)	0.00	8,986.62	17,053.21	0.00	4,036.01

Solvency Ratios

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Debt to Equity	-2.43	0.63	0.58	1.10	0.32
Short term debt to equity ratio	-1.91	0.25	0.15	0.69	0.11
Current Ratio	0.28	0.74	1.25	1.33	1.73
Quick Ratio	0.24	0.51	0.75	0.81	1.18
Interest Coverage	-2.50	-0.38	1.40	4.29	14.79

Operating Efficiency Ratios

	Syncom Healthcare	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Debtors to sales (%)	40.82	22.09	26.12	35.31	28.76
Asset Turnover	0.24	0.51	0.64	0.92	0.77
Receivable days	137.93	71.63	76.20	112.52	111.06
Inventory Days	85.19	65.71	74.72	99.96	70.18
Payable days	266.53	255.81	168.73	194.81	122.64
Cash Conversion Cycle	-43.41	-118.47	-17.80	17.67	58.60